OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

Understanding and overcoming resistance to immunotherapy in genitourinary cancers
S. Evans, Yash Jani, Caroline S. Jansen, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 10

Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
Richard Culliford, Samuel Lawrence, C. Mills, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
Lingqin Li, Fan Li, Zhehao Xu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance
Zhi Liu, Chunyu Zhang, Jiatong Xiao, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1966-1986
Open Access

Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access

Multiple roles of branched-chain amino acid metabolism in tumour progression
Zhen Li, Feng Shi, Ya Cao, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access

Genitourinary cancer neoadjuvant therapies: current and future approaches
Sujit S. Nair, Dimple Chakravarty, Vaibhav G. Patel, et al.
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1041-1057
Open Access | Times Cited: 10

Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+T cell infiltration and functional transition
Anze Yu, Jiao Hu, Liangmin Fu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007230-e007230
Open Access | Times Cited: 10

Identification of FLRT2 as a key prognostic gene through a comprehensive analysis of TMB and IRGPs in BLCA patients
Yaling Tao, Xiaoling Yu, Huaiwei Cong, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 3

Knowledge-map analysis of bladder cancer immunotherapy
Zongwei Lv, Junhui Hou, Yuan Wang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 7

Bcat2‐Mediated Branched‐Chain Amino Acid Catabolism Is Linked to the Aggravated Inflammation in Obese with Psoriasis Mice
Yazhuo Wang, Ning Zhao, Yujiao Meng, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 8
Closed Access | Times Cited: 2

Bibliometric insights into drug resistance in bladder cancer: Two decades of progress (1999–2022)
Yi‐Hsiang Huang, Ligang Chen, Yitong Zou, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31587-e31587
Open Access | Times Cited: 2

Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment
Qianquan Ma, Haoyu Li, Zhihao Song, et al.
Metabolism (2024) Vol. 161, pp. 156016-156016
Closed Access | Times Cited: 2

Therapeutic potential of vasculogenic mimicry in urological tumors
Xinyu Lin, Sheng Ru Long, Congcong Yan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top